IFNGR1
Interferon gamma receptor 1
As of the edition of 20 October 2026, IFNGR1 (interferon gamma receptor 1, UniProt P15260) has 1 drug tested at it and 1 company on the list, 0 on route A and 0 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- P15260
- How well studied
- Biology documented; no tool compounds or approved drug yet
- Where it sits in the cell
- At a membrane
- Solved structures
- 5
- Disease areas
- Infections; Cancer; Lungs and airways; Immune system; Urinary and reproductive; Inherited and neonatal; Blood and lymph; Digestive system
- Registered trials of its drugs
- 87
Drugs at this target
| Status | Count |
|---|---|
| Marketed | 1 |
| Total | 1 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Interferon gamma-1b | Marketed | Phase 4 | Ended 2011 |
1 of 1 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Undetermined | 1 |
| Total on the list | 1 |